MedTech Dive September 29, 2025
The number of medtech funding rounds has declined in recent months, but the value of overall deals has increased, according to a new report from EY.
Medical device firms are splitting into “haves” and “have-nots,” with investors putting more money into fewer companies, according to a Monday report by EY.
The report analyzed medtech funding rounds and acquisitions from July 2024 to June 2025. During that time, medtech firms raised fewer funding rounds than previous years, but with larger amounts of money. Venture capital investment totaled $8.7 billion, a 20% increase compared to the year-ago period. Total funding rounds, however, declined 47% to a total of 237.
“I don’t think I’ve ever seen as many hundred-million-dollar venture financing rounds,” John...







